Early detection in 15 minutes or lessFeatured Products Promotional Features
Posted by: Dental Design 20th November 2023
All too-often, oral cancer is detected in the late stages. This can make treatment difficult, and heavily impact patients’ quality of life. When detected in stages I and II, the chances of survival are doubled.
As such, routine screening for oral cancer is essential and the BeVigilant™ OraFusion™ System from Vigilant Biosciences® produces a simple and accurate risk assessment to aid in early detection.
The non-invasive tool analyses saliva and, in 15 minutes or less, produces a report of either low, moderate, or elevated risk levels associated with oral cancer, to assist dentists in their decision making.
For more information about what could be a truly life-changing, pre-diagnostic test, please contact the team at Vigilant Biosciences® for a demo.